Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With COVID-19 Infection in Morocco.

IF 1.4 Q3 PEDIATRICS Global Pediatric Health Pub Date : 2024-10-28 eCollection Date: 2024-01-01 DOI:10.1177/2333794X241286772

Naima Amenzoui, Siham Zouiter, Meriem Nassid, Halima Kholaiq, Ikbal Belkhou, Ibtihal Benhsaien, Fatima Ailal, Fatima Adnane, Zineb Jouhadi, Ahmed Aziz Bousfiha

{"title":"Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With COVID-19 Infection in Morocco.","authors":"Naima Amenzoui, Siham Zouiter, Meriem Nassid, Halima Kholaiq, Ikbal Belkhou, Ibtihal Benhsaien, Fatima Ailal, Fatima Adnane, Zineb Jouhadi, Ahmed Aziz Bousfiha","doi":"10.1177/2333794X241286772","DOIUrl":null,"url":null,"abstract":"Introduction. This study aims to describe the clinical and paraclinical characteristics of Multisysteminflammatory syndrome in children (MIS-C). Methods. A retrospective study encompassing 52 children diagnosed with MIS-C according to the World Health Organization criteria, over a 3-year period at Abderrahim Harrouchi Hospital in Morocco. Results. The median age was 6 years (IQR: 1-14), with a sex ratio of 1.16 (28 boys and 24 girls). Clinical manifestations were predominantly characterized by fever in all cases (100%), respiratory and gastrointestinal symptoms in 30 cases (58%) and 23 cases (44%) respectively, and shock in 9 cases (17%). We noted a myocarditis in 6 cases (12%). The treatment comprised intravenous human Immunoglobulin combined with methylprednisolone in all patients (100%). Conclusion. The characteristics of our MIS-C patients were similar to those in the literature, but more studies are needed to confirm these results.","PeriodicalId":12576,"journal":{"name":"Global Pediatric Health","volume":"11 ","pages":"2333794X241286772"},"PeriodicalIF":1.4000,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11528631/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Global Pediatric Health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/2333794X241286772","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"PEDIATRICS","Score":null,"Total":0}

引用次数: 0

Abstract

Introduction. This study aims to describe the clinical and paraclinical characteristics of Multisysteminflammatory syndrome in children (MIS-C). Methods. A retrospective study encompassing 52 children diagnosed with MIS-C according to the World Health Organization criteria, over a 3-year period at Abderrahim Harrouchi Hospital in Morocco. Results. The median age was 6 years (IQR: 1-14), with a sex ratio of 1.16 (28 boys and 24 girls). Clinical manifestations were predominantly characterized by fever in all cases (100%), respiratory and gastrointestinal symptoms in 30 cases (58%) and 23 cases (44%) respectively, and shock in 9 cases (17%). We noted a myocarditis in 6 cases (12%). The treatment comprised intravenous human Immunoglobulin combined with methylprednisolone in all patients (100%). Conclusion. The characteristics of our MIS-C patients were similar to those in the literature, but more studies are needed to confirm these results.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

摩洛哥与 COVID-19 感染有关的儿童多系统炎症综合征 (MIS-C)。

导言本研究旨在描述儿童多系统炎症综合征（MIS-C）的临床和辅助临床特征。研究方法。根据世界卫生组织的标准，对摩洛哥 Abderrahim Harrouchi 医院 3 年内诊断出的 52 名儿童多系统炎症综合征（MIS-C）患者进行回顾性研究。研究结果。中位年龄为 6 岁（IQR：1-14），性别比为 1.16（28 名男孩和 24 名女孩）。所有病例的临床表现均以发热为主（100%），出现呼吸道和胃肠道症状的病例分别为 30 例（58%）和 23 例（44%），出现休克的病例为 9 例（17%）。我们注意到有 6 例（12%）患者患有心肌炎。所有患者（100%）都接受了静脉注射人免疫球蛋白和甲基强的松龙的治疗。结论我们的 MIS-C 患者的特征与文献报道的相似，但还需要更多的研究来证实这些结果。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊